ReForm Biologics Appoints Kevin Kavanaugh to CFO and Robert Mahoney to CSO
13 Oct 2021 //
BUSINESSWIRE
ReForm Biologics Bolsters Diversity With New Appointments to Board of Directors
21 Sep 2021 //
BUSINESSWIRE
ReForm Biologics Names Neal Muni, Executive VP and COO
14 Sep 2021 //
BUSINESSWIRE
ReForm Biologics Names Industry Veteran Jeff Hackman as Chief Executive Officer
08 Sep 2021 //
BUSINESSWIRE
Industry Veteran John Yee, MD, MPH Joins ReForm Biologics Board of Directors
04 Aug 2021 //
BUSINESSWIRE